BR vs COLL
Broadridge Financial Solutions Inc (BR) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
BR currently screens at market cap $17.65B and trailing P/E 16.3. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the BR and COLL stock pages for the full models.
Not investment advice.